1. Home
  2. NVCR vs CABO Comparison

NVCR vs CABO Comparison

Compare NVCR & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CABO
  • Stock Information
  • Founded
  • NVCR 2000
  • CABO 1980
  • Country
  • NVCR Switzerland
  • CABO United States
  • Employees
  • NVCR N/A
  • CABO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CABO Cable & Other Pay Television Services
  • Sector
  • NVCR Health Care
  • CABO Telecommunications
  • Exchange
  • NVCR Nasdaq
  • CABO Nasdaq
  • Market Cap
  • NVCR 1.9B
  • CABO 717.5M
  • IPO Year
  • NVCR 2015
  • CABO N/A
  • Fundamental
  • Price
  • NVCR $17.60
  • CABO $124.47
  • Analyst Decision
  • NVCR Buy
  • CABO Hold
  • Analyst Count
  • NVCR 7
  • CABO 3
  • Target Price
  • NVCR $32.43
  • CABO $231.00
  • AVG Volume (30 Days)
  • NVCR 1.4M
  • CABO 210.9K
  • Earning Date
  • NVCR 07-24-2025
  • CABO 07-31-2025
  • Dividend Yield
  • NVCR N/A
  • CABO 7.09%
  • EPS Growth
  • NVCR N/A
  • CABO N/A
  • EPS
  • NVCR N/A
  • CABO N/A
  • Revenue
  • NVCR $621,711,000.00
  • CABO $1,555,831,000.00
  • Revenue This Year
  • NVCR $5.56
  • CABO N/A
  • Revenue Next Year
  • NVCR $9.19
  • CABO N/A
  • P/E Ratio
  • NVCR N/A
  • CABO N/A
  • Revenue Growth
  • NVCR 18.27
  • CABO N/A
  • 52 Week Low
  • NVCR $14.17
  • CABO $121.37
  • 52 Week High
  • NVCR $34.13
  • CABO $437.00
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 49.74
  • CABO 36.92
  • Support Level
  • NVCR $16.81
  • CABO $126.35
  • Resistance Level
  • NVCR $18.59
  • CABO $137.88
  • Average True Range (ATR)
  • NVCR 0.74
  • CABO 6.48
  • MACD
  • NVCR 0.08
  • CABO 1.54
  • Stochastic Oscillator
  • NVCR 56.18
  • CABO 11.85

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: